Wellcome Trust/MRC Strategic Award: Mechanisms of neurotoxicity of amyloid aggregates
| Title | Forname | Surname | Institution | Country |
| Professor | Peter | St George Hyslop | University of Cambridge | UK |
| Institution | Cambridge Institute for Medical Research |
| Street Address | Wellcome Trust/MRC Building, Addenbrooke’s Hospital, Hills Road |
| City | Cambridge |
| Postcode | CV2 0XY |
- United Kingdom
Medical Research Council
7151557.53
01-01-2010
60
- Alzheimer’s disease and other dementias
Some of the most important but unresolved questions about the pathobiology of Alzheimer’s disease (AD) are: What are the neurotoxic species of Abeta? How do they injure neurons? How do they induce aggregation of intracellular proteins like tau, alpha-synuclein, and TDP-43? Why are the normal mechanisms for removal of these intracellular aggregation-prone proteins overwhelmed in AD? Answers to such questions will provide both insight into the early stages of disease pathogenesis, and starting points for the discovery of novel diagnostics and therapeutics.
We hypothesize that the neurotoxicity of Abeta arises from heterogeneous mixtures of soluble Abeta aggregates, which may have differing toxicities, but which activate complex, interlinked downstream pathways. To deconvolute this complexity we will apply an integrated suite of tools from physics, chemistry, engineering, systems biology and neurobiology to: 1) Investigate Abeta aggregation and its consequences in living cells and animals; 2) Identify its molecular targets; 3) Discover the downstream metabolic and signalling pathways activated by Abeta; 4) Identify the molecular mechanisms by which Abeta induces misprocessing of tau; and 5) Identify the regulators of autophagy (which is an important physiological mechanisms for removal of tau) and determine why autophagy is down-regulated in AD)